Antibodies for Life
Human antibodies patrol the human body searching specifically for pathogens tagging these for a “natural therapy” through the immune system. Human evolution has constantly optimized antibodies over millions of years to serve one key purpose: to protect life. MorphoSys is committed to tap the potential of antibodies and to further expand the spectrum of possible applications for the sake of patients. With currently some 80 distinct drugs in research and development, MorphoSys has one of the broadest antibody pipelines in the biotechnology industry. Seventeen compounds are already being evaluated in clinical development and tested as options for treatment of severe and in many cases life-threatening diseases.
Modern diagnostics offer additional fields of application for MorphoSys’s technologies and products. Beyond the conventional disease diagnosis, diagnostic tools also play an increasingly important role in the development of new drugs and in many therapy decisions. MorphoSys’s technologies are ideally positioned at the nexus of these areas and the Company expects a number of new opportunities for collaboration with the diagnostics industry. The medical and commercial potential of antibodies in modern research, diagnostics and medicine continues to be enormous. MorphoSys has developed industry-leading technological solutions for the generation of antibodies and continues refining these methods to bring the best-possible antibody products into clinical application. Therapeutic antibodies developed by MorphoSys promise to considerably improve the quality of patients’ lives in the years ahead.